Amir Belson: Stealth Medtech Entrepreneur
Executive Summary
Amir Belson is among the most prolific device entrepreneurs in the industry today, having launched a dozen companies in the past 12 years. Not as well-known as other physician-inventors, he combines an aggressive IP strategy with an innovative approach to early-stage financing to launch companies in a variety of clinical spaces.
You may also be interested in...
Hypothermia Device Companies Continue To Wage Cold War
For therapeutic hypothermia device companies, the clinical trials that came before have been inconclusive, but they have provided insights to incorporate into the development of next-generation technologies. START-UP interviews two hypothermia device companies with novel approaches: Thermocure and ThermopeutiX.
Avinger: Finally, Seeing Through Total Occlusions, But Will Clinical Value Generate Economic Return?
Noted physician/entrepreneur John Simpson is back. His latest company, Avinger, has finally achieved his long-sought goal: combining imaging and therapeutics in catheter technology for crossing CTOs. Will clinical innovation be enough to reward Avinger in an increasingly economically focused medtech world?
VasoStitch Inc.
Delivering valve devices to a structurally damaged heart through the femoral artery can be a tricky proposition. Cardiologists normally gain access through a large incision and employ balloons to increase the diameter of the aperture. Problems can arise when trying to close the hole at the end of the procedure. New technology from VasoStitch Inc. allows for simpler and safer access and closure of catheter-based interventions for minimally invasive valve replacement and repair. The start-up’s two devices, yet to be branded, are for accessing the heart through the femoral artery (transfemorally) and the chest wall (transapically), respectively